228 related articles for article (PubMed ID: 21685039)
1. Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.
Kelesidis T; Aish L; Steller MA; Aish IS; Shen J; Foukas P; Panayiotides J; Petrikkos G; Karakitsos P; Tsiodras S
Am J Clin Pathol; 2011 Jul; 136(1):119-27. PubMed ID: 21685039
[TBL] [Abstract][Full Text] [Related]
2. Genital human papillomavirus testing by in situ hybridization in liquid atypical cytologic materials and follow-up biopsies.
Bewtra C; Xie Q; Soundararajan S; Gatalica Z; Hatcher L
Acta Cytol; 2005; 49(2):127-31. PubMed ID: 15839614
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.
Hesselink AT; van den Brule AJ; Brink AA; Berkhof J; van Kemenade FJ; Verheijen RH; Snijders PJ
Cancer; 2004 Feb; 102(1):11-8. PubMed ID: 14968413
[TBL] [Abstract][Full Text] [Related]
4. Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV.
Qureshi MN; Rudelli RD; Tubbs RR; Biscotti CV; Layfield LJ
Diagn Cytopathol; 2003 Sep; 29(3):149-55. PubMed ID: 12951683
[TBL] [Abstract][Full Text] [Related]
5. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.
Birner P; Bachtiary B; Dreier B; Schindl M; Joura EA; Breitenecker G; Oberhuber G
Mod Pathol; 2001 Jul; 14(7):702-9. PubMed ID: 11455003
[TBL] [Abstract][Full Text] [Related]
6. Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia.
Lie AK; Skjeldestad FE; Hagen B; Johannessen E; Skarsvåg S; Haugen OA
APMIS; 1997 Feb; 105(2):115-20. PubMed ID: 9113073
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Gong Y; Deavers M; Silva EG; Jan YJ; Cogdell DE; Luthra R; Lin E; Lai HC; Zhang W; Sneige N
J Clin Microbiol; 2008 Jan; 46(1):274-80. PubMed ID: 17977987
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
Söderlund-Strand A; Rymark P; Andersson P; Dillner J; Dillner L
J Clin Microbiol; 2005 Jul; 43(7):3260-6. PubMed ID: 16000445
[TBL] [Abstract][Full Text] [Related]
10. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of PCR in situ hybridization as a technique for morphological detection of human papillomavirus in uterine cervical neoplasia.
Oguchi T; Sato S; Xiao YH; Yokoyama Y; Saito Y
Eur J Gynaecol Oncol; 2000; 21(6):585-7. PubMed ID: 11214615
[TBL] [Abstract][Full Text] [Related]
12. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
13. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
14. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
[TBL] [Abstract][Full Text] [Related]
15. Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization.
Manavi M; Bauer M; Pischinger K; Czerwenka K
Arch Pathol Lab Med; 2001 Mar; 125(3):353-7. PubMed ID: 11231482
[TBL] [Abstract][Full Text] [Related]
16. Can human papillomavirus DNA testing substitute for cytology in the detection of high-grade cervical lesions?
Lee KJ; Lee JK; Saw HS
Arch Pathol Lab Med; 2004 Mar; 128(3):298-302. PubMed ID: 14987159
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus testing in women with mild cytologic atypia.
Bergeron C; Jeannel D; Poveda J; Cassonnet P; Orth G
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):821-7. PubMed ID: 10831974
[TBL] [Abstract][Full Text] [Related]
19. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.
Sheng Z; Minato H; Sasagawa T; Nakada S; Kinoshita E; Kurose N; Nojima T; Makinoda S
Int J Clin Exp Pathol; 2013; 6(10):2168-77. PubMed ID: 24133595
[TBL] [Abstract][Full Text] [Related]
20. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
